Clinical Trials Logo

Clinical Trial Summary

This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. pattern of pathogenic-wind are randomly divided into treatment and control group, with 60 patients in each group. Clinical observation of the Respiratory Impedance and Inflammation in Cough Variant Asthma adults reated in Combination of Chanqin Granules.


Clinical Trial Description

This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. pattern of pathogenic-wind are randomly divided into treatment and control group, with 60 patients in each group. All patients enrolled are treated with Budesonide + Formoterol Fumarate dry power (160/4.5ug bid) for inhalation. The treatment group are given additional Chanqin granulate (10g bid) and placebo granulate for controlled group. Investigators hypothesis that Chanqin granules may reduce day & night cough score as well as the respiratory impedance, inflammation statues, and improve T.C.M. syndrome after 8 weeks of treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03319043
Study type Interventional
Source Shanghai University of Traditional Chinese Medicine
Contact XUAN CHEN, Master
Phone +86-13611899735
Email chen77xuan@aliyun.com
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date November 1, 2017
Completion date June 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04171180 - The Efficacy of Budesonide/Formoterol in Cough Variant Asthma Phase 4
Recruiting NCT03105843 - Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol Phase 4
Recruiting NCT05459805 - Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine N/A
Unknown status NCT02002754 - The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Phase 4
Not yet recruiting NCT01170429 - Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) Phase 4
Completed NCT04203472 - Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma N/A
Recruiting NCT03169699 - Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data N/A
Completed NCT01064245 - Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challenge Tests N/A
Completed NCT03363698 - MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough
Completed NCT03573284 - Validity of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma N/A
Completed NCT00660114 - Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients N/A